REMUS2026-10-28REMUS2026-10-282026-10-28xbrli:pureREMUSRemus Pharmaceuticals LimitedtrueINE0O5T01011Board MeetingNew2026-11-03true2026-10-0105-11-20262026-10-28Financial resultsDividendOther businessUnauditedStandalone And ConsolidatedHalf YearlySeptember2026InterimWith refernce to our earlier intimation dated September 25, 2026, whereby, pursuant to the Company’s Code of Conduct framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended (“the Code”), the Trading Window for dealing in securities of the Company, for persons specified under the Code, was closed from October 01, 2026 till 48 hours after the Unaudited Standalone and Consolidated Financial Results of the Company for the half year ended September 30, 2026 are approved by the Board of Directors and submitted to Stock Exchange.